Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1030268.RADfhn51-wEsCz7Od6YXFYv8Oe6b7baW77Og7FaNScs6Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1030268.RADfhn51-wEsCz7Od6YXFYv8Oe6b7baW77Og7FaNScs6Y130_assertion type Assertion NP1030268.RADfhn51-wEsCz7Od6YXFYv8Oe6b7baW77Og7FaNScs6Y130_head.
- NP1030268.RADfhn51-wEsCz7Od6YXFYv8Oe6b7baW77Og7FaNScs6Y130_assertion description "[Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1030268.RADfhn51-wEsCz7Od6YXFYv8Oe6b7baW77Og7FaNScs6Y130_provenance.
- NP1030268.RADfhn51-wEsCz7Od6YXFYv8Oe6b7baW77Og7FaNScs6Y130_assertion evidence source_evidence_literature NP1030268.RADfhn51-wEsCz7Od6YXFYv8Oe6b7baW77Og7FaNScs6Y130_provenance.
- NP1030268.RADfhn51-wEsCz7Od6YXFYv8Oe6b7baW77Og7FaNScs6Y130_assertion SIO_000772 23172668 NP1030268.RADfhn51-wEsCz7Od6YXFYv8Oe6b7baW77Og7FaNScs6Y130_provenance.
- NP1030268.RADfhn51-wEsCz7Od6YXFYv8Oe6b7baW77Og7FaNScs6Y130_assertion wasDerivedFrom befree-2016 NP1030268.RADfhn51-wEsCz7Od6YXFYv8Oe6b7baW77Og7FaNScs6Y130_provenance.
- NP1030268.RADfhn51-wEsCz7Od6YXFYv8Oe6b7baW77Og7FaNScs6Y130_assertion wasGeneratedBy ECO_0000203 NP1030268.RADfhn51-wEsCz7Od6YXFYv8Oe6b7baW77Og7FaNScs6Y130_provenance.